Advertisement

Topics

Novo Nordisk Awards $40M Automation Contract For New U.S. Manufacturing Facility

08:00 EST 15 Nov 2017 | Pharmaceutical Processing

Novo Nordisk's new $2 billion manufacturing plant in Clayton, N.C., due to be operational in 2020, aims to bring medication to market more quickly to address the growing diabetes problem.
Contributed Author: 
Novo Nordisk A/S
Topics: 

Original Article: Novo Nordisk Awards $40M Automation Contract For New U.S. Manufacturing Facility

NEXT ARTICLE

More From BioPortfolio on "Novo Nordisk Awards $40M Automation Contract For New U.S. Manufacturing Facility"

Advertisement
Quick Search
Advertisement
Advertisement